- Filed
- Apr 22, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 15, 2026 | 110.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 112M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 113M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $88M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $84M |
| Capex | Q1 2026 · Mar 31, 2026 | $114M |
| Capex | Q1 2026 · Mar 31, 2025 | $117M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $278M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $314M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $393M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $420M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $7.37B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $7.17B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.18B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.28B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.57B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.38B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $16.67B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $16.23B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $2.24 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.94 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $2.27 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.97 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $504M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $476M |
| Net Income | Q1 2026 · Mar 31, 2026 | $252M |
| Net Income | Q1 2026 · Mar 31, 2025 | $220M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $399M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $346M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.95B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $1.79B |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.9B |
| Revenue | Q1 2026 · Mar 31, 2025 | $2.65B |